Uncategorized

Innovent Biologics, Inc. announces that full results from a Phase 2 clinical trial of mazdutide, a glucagon-like peptide-1 receptor and glucagon receptor dual agonist, in Chinese patients with type 2 diabetes were published in Diabetes Care.

After reviewing the outcomes of 1,200 clinical studies, the firm says it can help most biopharmas set their trials up for success while cutting costs in half.

When twins Kenzie and Kaylie were diagnosed with Rett syndrome in 2016, there was no dedicated treatment for the neurodevelopmental disorder. That changed this year with the approval of Acadia Pharmaceuticals’ Daybue.

The market size for biologic oncology therapies will reach $786 billion by 2029, far outstripping small molecules, a GlobalData report predicts.

The CEO said the company’s growth expectations have not changed in the near term, even with the rise of weight loss drugs.

The company is the latest medtech to address concerns about how weight loss drugs may impact growth.

The Washington-based nonprofit said their policies center care, “not maximizing collections.” The state’s attorney general said the hospital failed to notify patients about financial assistance options.

Los paneles solares tienen que estar expuestos a la radiación solar para poder generar energía, aunque también están en contacto con los elementos del clima. Por lo tanto, si vives en un lugar donde el polvo, nieve, arena, o la polución es alta, tendrás que …

The current partnership, which operates M Health Fairview, will end in 2026, but negotiations toward a new contract will continue, according to the nonprofit.

Hospitals and nursing unions clash on what’s driving sluggish application rates for open registered nurse positions at hospitals  — a lack of qualified candidates or a lack of interest.